AppPage.net

Screenshots

  • DS7300-188 screenshot 1
  • DS7300-188 screenshot 2

About DS7300-188

A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.

What’s new

Version 5.5.700.5-prod · Updated July 23, 2024

Bug fixes

Alternatives to DS7300-188

Looking for apps like DS7300-188? Here are 6 similar Android apps on Google Play. The highest rated is Medable (4.0/5), and all 6 are free to download.

DS7300-188 vs. alternatives
App Rating Price Installs Last updated Compare
DS7300-188 – Free 50+ Jul 23, 2024
Medable 4.0 / 5 Free 10,000+ Sep 30, 2026 Compare
J1I-MC-GZQD – Free 500+ Jan 28, 2026 Compare
Avanti – Free 500+ Dec 2, 2025 Compare
GSK 219685 – Free 100+ Mar 14, 2025 Compare
GSK 219855 France – Free 1+ Oct 23, 2025 Compare
GSK 221458 – Free 10+ Mar 14, 2025 Compare

Compare DS7300-188 with the top alternatives: ratings, updates, ASO score and keyword gaps →

Similar apps on Google Play